Leucadia National Corporation »

Biomarin Pharma Inc convertible/ shares owned by Leucadia National Corporation

Quarter-by-quarter ownership of Biomarin Pharma Inc convertible/ shares owned by Leucadia National Corporation from 13F filings

Historical chart of Leucadia National Corporation investment in Biomarin Pharma Inc convertible/

Tip: Access up to 7 years of quarterly data

All positions including Biomarin Pharma Inc convertible/ held by Leucadia National Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biomarin Pharma Inc convertible/ by Leucadia National Corporation

Quarter filed Position value Share count Share price at filing
2023-09-30 $11M 11M 0.98
2023-06-30 $13M 14M 0.98

More positions owned by Leucadia National Corporation

Spdr Gold Tr Gold Shs (GLD)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Activision Blizzard
Delta Air Lines Inc Del Com New (DAL)
Ishares Tr Russell 2000 Etf (IWM)
Apple (AAPL)
Select Sector Spdr Tr Energy (XLE)
Palo Alto Networks (PANW)
Meta Platforms Cl A (META)
Spdr Ser Tr S&p Biotech (XBI)
Alphabet Cap Stk Cl A (GOOGL)
NVIDIA Corporation (NVDA)
Intel Corporation (INTC)

View all positions for Leucadia National Corporation

Top funds holding Biomarin Pharma Inc convertible/

OZ Management
Millennium Management
Citigroup
Aviva
Two Sigma Investments
Calamos Advisors
Partner Fund Management
Bank of America Corporation
Lord, Abbett & Co
Sunrise Partners Limited Partnership
Centiva Capital
Jpmorgan Chase & Co
RWC Asset Management
MacKay Shields
Palisade Capital Management

View all funds holding Biomarin Pharma Inc convertible/